Heart-hitting tales of salt and destruction

Journal of Laboratory and Clinical Medicine

Volumn 136, Issue 1, 2000, Pages 7-13

  Weber, Karl T ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0033797061     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1067/mlc.2000.107301     Document Type: Conference Paper

References (59)

1. Presidential address. Part I: Painting background. Part II: Primary aldosteronism, a new clinical syndrome
2. Primary aldosteronism
3. Aldosteronism in man. Some clinical and climatological aspects. Part II
4. Primary aldosteronism: Present evaluation of its clinical characteristics and of the results of surgery
5. Disorders of the adrenal cortex
6. The general adaptation syndrome and the diseases of adaptation
7. Hypertension and hypersalimentation. I. Aldosterone hypertension
8. Collagen network remodeling and diastolic stiffness of the rat left ventricle with pressure overload hypertrophy
9. Malignant hypertension resulting from deoxycorticosterone acetate and salt excess
10. Remodeling of the rat right and left ventricle in experimental hypertension
11. Mineralocorticoid blockade reduces vascular injury in stroke-prone hypertensive rats
12. Primary aldosteronism with malignant hypertension
13. Clinical, biochemical and pathological features of low-renin ('primary') hyperaldosteronism
14. Renal abnormalities and vascular complications in primary hyperaldosteronism. Evidence on tertiary hyperaldosteronism
15. Left ventricular hypertrophy precedes other target-organ damage in primary aldosteronism
16. Hypertensive complications in patients with primary aldosteronism
17. Malignant hypertension with aldosteronoma producing adenoma
18. The role of blood pressure and aldosterone in the production of hemorrhagic stroke in captopril-treated hypertensive rats
19. Pathologic remodeling of the myocardium in a weightlifter taking anabolic steroids
20. Fibrosis of the human heart and systemic organs in adrenal adenoma
21. The evolution of primary aldosteronism: 1954-1967
22. The correspondence of S.A.S. Simpson and J.F. Tait with T. Reichstein during their collaborative work on the isolation and elucidation of the structure of electrocortin (later aldosterone)
23. The effect of spironolactone on morbidity and mortality in patients with severe heart failure
24. Sodium-dependent modulation of the renal Na-K-ATPase: Influence of mineralocorticoids on the cortical collecting duct
25. Aldosterone and antialdosterone therapy in congestive heart failure
26. Aldosterone escape during angiotensin-converting enzyme inhibitor therapy in chronic heart failure
27. The physiology of congestive heart failure
28. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. Consensus Trial Study Group
29. A light and electron microscope analysis of vascular injury
30. Reactive and reparative fibrosis in the hypertrophied rat left ventricle: Two experimental models of myocardial fibrosis
31. Myocardial stiffness and reparative fibrosis following coronary embolization in the rat
32. Structural basis of end-stage failure in ischemic cardiomyopathy in humans
33. Pathological hypertrophy and cardiac interstitium: Fibrosis and renin-angiotensin-aldosterone system
34. Myocardial fibrosis: Functional significance and regulatory factors
35. Endocrine control of connective tissue
36. High affinity aldosterone binding sites (type I receptors) in rat heart
37. Internal image properties of a monoclonal auto-anti-idiotypic antibody and its binding to aldosterone receptors
38. Glucocorticoids and mineralocorticoids: Antifibrotic and profibrotic components of wound healing
39. Mineralocorticoid excess, dietary sodium and myocardial fibrosis
40. Fibrosis of atria and great vessels in response to angiotensin II or aldosterone infusion
41. Relation of plasma renin to end organ damage and to protection of K+ feeding in stroke-prone hypertensive rats
42. Aldosterone reverses the protective effects of adrenalectomy against end-organ damage in stroke-prone spontaneously hypertensive rats
43. Increased cardiac types I and III collagen mRNAs in aldosterone-salt hypertension
44. Mineralocorticoids, hypertension, and cardiac fibrosis
45. Angiotensin II and aldosterone receptor binding in rat heart and kidney: Response to chronic angiotensin II or aldosterone administration
46. Mineralocorticoid binding in cultured smooth muscle cells and fibroblasts from rat aorta
47. Angiotensin converting enzyme and myocardial fibrosis in the rat receiving angiotensin II or aldosterone
48. Glucocorticoid metabolism in the cardiac interstitium: 11β-Hydroxysteroid dehydrogenase activity in cardiac fibroblasts
49. The promiscuous receptor: A case for the guardian enzyme
50. Collagen metabolism in cultured adult rat cardiac fibroblasts: Response to angiotensin II and aldosterone
51. Aldosterone and cardiac fibrosis: In vitro studies
52. Extra-adrenal mineralocorticoids and cardiovascular tissue
53. Aldosterone biosynthesis and action in vascular cells
54. Expression of 11β-hydroxysteroid dehydrogenase mRNA in rat vascular smooth muscle cells
55. Synthesis of corticosterone in the vascular wall
56. Production of aldosterone in isolated rat blood vessels
57. Regulation of aldosterone synthase in human vascular endothelial cells by angiotensin II and adrenocorticotropin
58. Myocardial production of aldosterone and corticosterone in the rat
59. Inhibition of tissue repair by spironolactone: Role of mineralocorticoids in fibrous tissue formation